BIA 10-2474 experimental drug molecule. Fatty acid amide hydrolase (FAAH) inhibitor that caused severe adverse events in a clinical trial in France in
BIA 10-2474 experimental drug molecule. Fatty acid amide hydrolase (FAAH) inhibitor that caused severe adverse events in a clinical trial in France in 2016. 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey), oxygen (red), nitrogen (blue).
Size: 8000px × 6000px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No
Keywords: 10-2474, 3d, acid, adverse, amide, anandamide, animal, anxiety, atomic, atoms, bia, brain, carbon, chemical, chemistry, clinical, cns, composition, death, disease, dose, drug, endocannabinoid, event, fatty, hydrogen, hydrolase, illustration, inhibitor, medicinal, medicine, model, molecular, molecule, neurological, neurology, nitrogen, oxygen, parkinson, participant, pharma, pharmaceutical, pharmacology, pharmacy, phase, rendering, severe, spinal, testing, therapy, toxic, toxicology, treatment, trial
